Literature DB >> 10737127

Histopathology and APOE genotype of the first Alzheimer disease patient, Auguste D.

M B Graeber1, S Kösel, E Grasbon-Frodl, H J Möller, P Mehraein.   

Abstract

Alois Alzheimer published two papers on the disease which was named after him by Emil Kraepelin in 1910. Each of these papers contains clinical and pathological data on a patient Alzheimer had seen at the hospital. We have previously reported on the rediscovery of tissue sections from Alzheimer's second published case of Alzheimer disease, Johann F., which probably gave the disease its name (Neurogenetics 1997; 1:73-80). Here, we describe the histopathology and APOE genotype of Alois Alzheimer's first patient, Auguste D. As in the case of Johann F., a large number of tissue sections belonging to Alzheimer's laboratory, which was later headed by Spielmeyer, were found among material kept at the Institute of Neuropathology of the University of Munich. As described by Alzheimer in his original report (Allg Zeitschr Psychiatr 1907; 64:146-148), there were numerous neurofibrillary tangles and many amyloid plaques, especially in the upper cortical layers of this patient. Yet, there was no microscopic evidence for vascular, i.e., arteriosclerotic, lesions. Interestingly, Alzheimer's histological preparations did not include the hippocampus or entorhinal region. The APOE genotype of this patient was shown to be epsilon3/epsilon3 by PCR-based restriction enzyme analysis, indicating that mutational screening of the tissue is feasible. The historical importance of the case of Auguste D. lies in the fact that it marks the beginning of research into Alzheimer disease. In addition, neurofibrillary tangles were first described in this brain.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10737127     DOI: 10.1007/s100480050033

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  9 in total

1.  The N141I mutation in PSEN2: implications for the quintessential case of Alzheimer disease.

Authors:  Chang-En Yu; Elizabeth Marchani; Georg Nikisch; Ulrich Müller; Dagmar Nolte; Andreas Hertel; Ellen M Wijsman; Thomas D Bird
Journal:  Arch Neurol       Date:  2010-05

2.  [Amyloidoses in the Berlin Museum of Medical History of the Charité].

Authors:  C Röcken; N Widulin; T Schnalke
Journal:  Pathologe       Date:  2009-05       Impact factor: 1.011

3.  Alzheimer and his disease: a brief history.

Authors:  Gabriele Cipriani; Cristina Dolciotti; Lucia Picchi; Ubaldo Bonuccelli
Journal:  Neurol Sci       Date:  2010-12-11       Impact factor: 3.307

Review 4.  Oxidative Stress in Alzheimer's Disease: Should We Keep Trying Antioxidant Therapies?

Authors:  Michelli Erica Souza Ferreira; Amanda Soares de Vasconcelos; Thyago da Costa Vilhena; Thiago Leite da Silva; Aline da Silva Barbosa; Antonio Rafael Quadros Gomes; Maria Fani Dolabela; Sandro Percário
Journal:  Cell Mol Neurobiol       Date:  2015-01-24       Impact factor: 5.046

5.  Perceptions of tissue storage in a dementia population among spouses and offspring.

Authors:  Megan M Martin; Erin W Rothwell; Vickie L Venne; Norman L Foster
Journal:  J Genet Couns       Date:  2015-02-03       Impact factor: 2.537

Review 6.  Neuropathology for the neuroradiologist: plaques and tangles.

Authors:  F J Wippold; N Cairns; K Vo; D M Holtzman; J C Morris
Journal:  AJNR Am J Neuroradiol       Date:  2007-10-09       Impact factor: 3.825

7.  Alois Alzheimer: his life and times.

Authors:  Michel Goedert; Bernardino Ghetti
Journal:  Brain Pathol       Date:  2007-01       Impact factor: 6.508

8.  Molecular and Immunohistochemical Characterization of Historical Long-Term Preserved Fixed Tissues from Different Human Organs.

Authors:  Maja Hühns; Paula Röpenack; Andreas Erbersdobler
Journal:  PLoS One       Date:  2015-08-07       Impact factor: 3.240

Review 9.  Alzheimer's Disease: Mechanism and Approach to Cell Therapy.

Authors:  Takashi Amemori; Pavla Jendelova; Jiri Ruzicka; Lucia Machova Urdzikova; Eva Sykova
Journal:  Int J Mol Sci       Date:  2015-11-04       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.